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Abstract
RNA viruses generate nonstandard viral genomes during their replication, including viral genomes of the copy-back (cbVGs) type that
cannot replicate in the absence of a standard virus. cbVGs play a crucial role in shaping virus infection outcomes due to their ability to
interfere with virus replication and induce strong immune responses. However, despite their critical role during infection, the principles
that drive the selection and evolution of cbVGs within a virus population are poorly understood. As cbVGs are dependent on the virus
replication machinery to be generated and replicated, we hypothesized that host factors that affect virus replication exert selective
pressure on cbVGs and drive their evolution within a virus population. To test this hypothesis, we used respiratory syncytial virus (RSV)
as a model and took an experimental evolution approach by serially passaging RSV in immune-competent human lung adenocarcinoma
A549 control and immune-deficient A549 Signal transducer and activator of transcription 1 (STAT1) KO cells, which allow higher levels of
virus replication. As predicted, we observed that virus populations accumulated higher amounts of cbVGs in the more permissive A549
STAT1 KO cells over time; however, unexpectedly, the predominant cbVG species after passages in the two conditions were different.
While A549 STAT1 KO cells accumulated relatively short cbVGs, A549 control cells mainly contained cbVGs of much longer predicted size,
which have not been described previously. These long cbVGs were predominant at first in both cell lines in vitro and the predominant
ones observed in samples from RSV-infected patients. Although sustained high replication levels are associated with cbVG generation
and accumulation, our data show that sustained high levels of virus replication are critical for cbVG population diversification, a process
that precedes the generation of shorter cbVGs that selectively accumulate over time. Taken together, we show that selection and
evolution of cbVGs within a virus population are shaped by how resistant or permissive a host is to RSV.

Key words: respiratory syncytial virus; copy-back viral genomes; experimental evolution.

1. Introduction
The ability of RNA viruses to rapidly evolve is a major concern
for public health due to the potential emergence of virus variants
with enhanced pathogenicity (Carrasco-Hernandez et al. 2017). It
is, therefore, of critical importance to understand the principles
that drive virus evolution. An RNA virus consists of communities of standard viral genomes and nonstandard viral genomes,
such as copy-back viral genomes (cbVGs), which are generated
during virus replication (Vignuzzi and Lopez 2019). Of note, cbVGs
are also known as ‘defective viral genomes’ or DVGs. Since the
word ‘defective’ may give the wrong impression that cbVGs have
no function during a viral infection, we herein call them cbVGs,
as these kinds of genomes do play important roles during infeć
tion (Vignuzzi and Lopez 2019; González-Aparicio, Lopez,
and Felt
2022).

cbVGs are generated when the polymerase detaches from the
template strand at a break point and resumes elongation at a
downstream rejoin point creating a complementary end to the
5′ end of the nascent genome (Kolakofsky 1976; Lazzarini, Keene,
and Schubert 1981; Vignuzzi and Lopez 2019). cbVGs are usually
shorter than standard viral genomes, and their flanking trailer
promoters have a higher affinity for the viral polymerase than
the leader promoter present at the 3′ end of the standard viral
genome, thereby providing a replication advantage to cbVGs (Rao
and Huang 1982; Li and Pattnaik 1997). This advantage in replication can lead to the accumulation (significant increase) of shorter
cbVGs within virus populations. cbVGs depend on standard viral
genomes to be generated and replicated. Many cbVGs are packaged and released from the infected cell and can infect new
host cells affecting the interaction of the virus with the host
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2. Methodology

5 per cent CO2 and 37∘ C in Dulbecco’s modified Eagle’s medium
supplemented with 10 per cent fetal bovine serum, 1 mM sodium
pyruvate, 2 mM l-glutamine, and 50 mg/ml gentamicin. The A549
Clustered Regularly Interspaced Short Palindromic Repeats cell
lines were kindly provided by Dr. Susan Weiss (University of
Pennsylvania) and have been previously characterized (Xu et al.
2017; Whelan et al. 2019). All cell lines were treated with
Mycoplasma removal agent (MP Biomedicals) and routinely tested
for Mycoplasma before use. RSV A2 was obtained from ATCC
(#VR-1540) and amplified in Hep2 cells at a low MOI of 0.01 to
generate RSV stocks with low cbVG contents (Sun and Lopez
2016). We used these stocks as parental (P0) virus stocks for our
experiments.

2.2 Passaging experiments
In fixed-volume passaging experiments, for the first passage, A549
control and STAT1 KO cells were infected at an MOI of ten with
an RSV stock with a low cbVG content (P0) to focus mainly on de
novo generation of cbVGs. We chose this MOI as higher MOIs favor
the accumulation of nonstandard viral genomes, including cbVGs,
in virus populations (Von Magnus 1951; 1954; Kingsbury, Portner,
and Darlington 1970; Stampfer, Baltimore, and Huang 1971; Huang
1973; Thompson and Yin 2010; Sun and Lopez 2016; Welch et al.
2020). Two days postinfection (before too many cells start dying
(Collins, Fearns, and Graham 2013)), cells were collected and
centrifuged for five minutes at 280 × g to separate supernatant
from cells. Most of the supernatant was transferred to a new
tube and kept on ice to preserve viral particles. The remaining
supernatant was left to cover the cell pellet to make sure that
the cells did not dry. As most RSV particles remain attached to
cells (Collins, Fearns, and Graham 2013), three freeze/thaw (dry
ice/ethanol + 37∘ C water bath) cycles were performed on the cell
pellet to release virus particles. Pellets were vortexed after each
freeze/thaw cycle to further increase virus particle release. Pellets were then centrifuged for five minutes at 280 × g to separate
cell debris from supernatant with released viral particles. Supernatant from freeze/thaw cycles was then mixed with supernatant
that was kept on ice and 36 ul, which represents ∼1/25th of the
total mixed supernatant, was then used to infect the next round
of fresh cells (Passage 2). These procedures and volume were kept
consistent throughout the remaining passages. We chose a ratio
of ∼1/25 as in a previous study, it was shown to lead to accumulation of non-standard viral genomes (Williams et al. 2016).
At each passage, the remaining supernatant was snap frozen in
dry ice/ethanol to preserve viral particles for downstream analysis (titration and RNAseq/VODKA2 analysis). It is important to
note that, in addition to viral particles, the samples also contain
unpackaged viral RNAs.
For the fixed-MOI passaging experiment, A549 control and
STAT1 KO cells were initially infected at an MOI of 0.1 or 10 with
an RSV stock with a low cbVG content (P0). The steps between
each passage and preservation of samples were performed such as
for the fixed-volume experiment. However, supernatants were tittered in between each passage to maintain the same MOI throughout the ten passages. For the fixed MOI of ten experiments, an MOI
of ten was maintained if titer and volumes allowed it. For the first
six passages, it was possible to use an MOI of ten; however, for
Passages 7, 8, 9, and 10, the MOIs were reduced to 5, 8, 5, and 5,
respectively.

2.1 Cells and viruses

2.3 Titration

A549 control cells, A549 STAT1 KO cells, and HEp2 cells (HeLaderived human epithelial cells, ATCC CCL23) were cultured at

Supernatants were tittered by Median Tissue Culture Infectious
Dose (TCID50 ) on Hep2 cells to assess the amount of infectious
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(Lazzarini, Keene, and Schubert 1981; Vignuzzi and Lopez 2019).
cbVGs can inhibit standard viral genome replication by competing
for the virus replication machinery or by inducing innate immune
signaling pathways (Henle and Henle 1943; Strahle, Garcin, and
Kolakofsky 2006; Tapia et al. 2013; Sun et al. 2015). Despite the
critical role of cbVGs in shaping the infection outcome, most RNA
virus evolution studies only consider standard viral genomes. As a
result of this, the principles that drive the selection and evolution
of cbVGs within a virus population are poorly understood.
As cbVGs depend on the virus replication machinery to be generated and amplified, we hypothesized that host factors that affect
virus replication exert selective pressure on cbVGs and drive their
evolution within a virus population. To test this hypothesis, we
used the non-segmented negative-sense RNA virus respiratory
syncytial virus (RSV) as a model because RSV generates many
cbVGs during infection in vitro and in vivo (Treuhaft and Beem
1982; Sun et al. 2015; Felt et al. 2021). RSV cbVGs stimulate Mitochondrial antiviral-signaling (MAVS) signaling during infection,
which leads to the production of antiviral type I and III interferons (IFNs) (Sun et al. 2015). This antiviral response is dependent
on cbVGs triggering the intracellular viral sensors retinoic acidinducible gene I (RIG-I)-like receptors, as has been shown for
many non-segmented negative-sense RNA viruses (Strahle et al.
2007; Yount et al. 2008; Baum et al. 2010; Runge et al. 2014; Xu
et al. 2015; Ho et al. 2016; Mura et al. 2017; Linder et al. 2021).
The expression of type I and III IFNs leads to the activation of
STAT1, which is followed by the production of hundreds of proteins that interfere with virus replication (Mesev, LeDesma, and
Ploss 2019). Interestingly, recently, it has been shown that viruses
can activate STAT1 even earlier independent of IFNs through a
RIG-I/MAVS/Spleen tyrosine kinase (Syk) pathway further establishing STAT1 as an important antiviral protein (Liu et al. 2021).
In vivo, RSV can replicate to higher levels in STAT1-knockout mice
compared to wild-type mice (Durbin et al. 2002; Hashimoto et al.
2005; Stier et al. 2017). Based on these studies, we decided to test if
STAT1 exerts selective pressure on RSV cbVGs and drive their evolution. Specifically, we took an experimental evolution approach
and serially passaged RSV using a fixed-volume or a fixed multiplicity of infection (MOI) in immune-competent A549 control cells
or in immune-deficient A549 STAT1 KO cells. As RSV also generates cbVGs in infected patients (Felt et al. 2021; Sun et al. 2015),
we also analyzed cbVGs in nasal washes from RSV-infected pediatric patients to assess what cbVGs are selected for during natural
infections.
To detect cbVGs in RNAseq data, we used an updated version
of our previously published Viral Opensource DVG Key Algorithm
(VODKA) (Sun et al. 2019), called VODKA2, which identifies cbVG
reads based on their alignment to unique junction sequences that
contain a break and rejoin point. Predicted cbVG species sizes can
then be calculated based on the break and rejoin points. Our study
revealed that the diversity of cbVGs generated is much larger than
previously thought. We found that cbVGs of longer predicted sizes
that have not been described previously are predominant at first
in vitro and the major cbVGs present in samples from RSV-infected
patients. Furthermore, sustained high virus replication levels led
to cbVG population diversification that preceded the generation
and selective accumulation of shorter cbVGs.

S. A. Felt et al.
viral particles as previously published (Sun and Lopez 2016).
Briefly, supernatants were serially diluted, added on Hep2 cells,
and incubated for 4–5 days, and after addition of crystal violet, the
last dilution with cytopathic effect was determined to calculate
the TCID50 .

2.4 Nasopharyngeal aspirates

2.5 RNAseq
Total RNA was extracted using TRIzol LS (Invitrogen). RNA quality was assessed using an Agilent TapeStation or Bioanalyzer
(Agilent Technologies) before complementary deoxyribonucleic
acid (cDNA) library preparation. All samples were prepared using
the Illumina Non-Stranded Total RNA Library Prep Kit with RiboZero Gold. The only exceptions were the clinical samples, which
were prepared using the Sigma SeqPlex RNA Amplification Kit,
and the samples shown in Fig. S3, which were prepared using the
Illumina TruSeq Stranded Total RNA Library Prep Kit with RiboZero Gold. All samples were run on a NovaSeq 6000 to generate
150-bp, paired-end reads, resulting in ∼33–62 million reads per
sample. The only exceptions were samples shown in Fig. S3, which
were run on an Illumina NextSeq 500 to generate 75-bp, single-end
reads, resulting in ∼45–72 million reads per sample. Only R1 reads
were used for analysis as many reads in R2 were duplicates. The
average Phred quality score of samples ranged between 34.7 and
36.1. Raw RNAseq data from Figs S3 and S5A were used in previous
studies (Xu et al. 2017; Sun et al. 2019).

2.6 VODKA2
After trimming sequencing adapters (Illumina Universal
Adapter—AGATCGGAAGAG, https://support.illumina.com/) from
the 3′ end of the reads using Cutadapt (DOI: 10.14806/ej.17
.1.200) and removing all reads aligned to the human genome
(GRCh38, GRC website) with Bowtie2 (https://doi.org/10.1038/
nmeth.1923), an updated version of VODKA (VODKA2.0 beta,
https://github.com/eachouri/VODKA2/tree/main/VODKA2-v2.0bmaster) was used to detect cbVG junction reads derived from the
entire viral genome (in vitro reference genome KT992094.1 and
clinical samples reference genome KC731482.1). We only focused
on cbVGs generated from the 5′ end of the viral genome, which
are the best described in the literature (Vignuzzi and Lopez 2019).
Briefly, VODKA2.0 beta first runs a Bowtie2 alignment of the reads
against a database representing all theoretical cbVGs potentially
present in the data set (KT992094.1: 231,298,470 possibilities and
KC731482.1: 231,541,872 possibilities). Reads are removed unless
they map across break and rejoin junction sequences with at least
15 bp of mapped segment on each side. This is followed by an
extra filtering step based on the Basic Local Alignment Search
Tool (Blastn v.2.11.0,
https://doi.org/10.1016/S0022-2836(05)
80360-2) alignment of the predicted break and rejoin junction
sequences against the virus reference genome (BLAST options:
‘-word_size 11 -gapopen 5 -gapextend 2 -penalty −3 -reward 2
-evalue 0.001 -perc_identity 0.1’). Only sequences with two alignment ranges reported on opposite strands of the reference genome
are considered cbVG reads. Sequences with BLAST alignment positions that are not consistent with the initial Bowtie2 alignment
are discarded. An extended report is then generated, including in

particular the aggregation of cbVG junction reads into ‘species’,
i.e., junction reads leading to cbVGs of the exactly same theoretical size but with break and rejoin occurring within a range of ±5
nucleotides. ‘Species’ with only one read were removed from analysis. Break and rejoin positions from VODKA2.0 beta were used
to calculate the predicted size of cbVGs [(break position − genome
size) + (rejoin position − genome size) + 2].

2.7 Statistical analysis
Statistical analyses were performed as indicated in each figure
legend using GraphPad Prism v.9.

3. Results
3.1 cbVGs accumulate to higher levels after
twenty passages in A549 STAT1 KO cells than in
A549 control cells
To examine the evolution of cbVG populations and selection of
cbVG species, we passaged a fixed volume of supernatant from
RSV-infected cells twenty times in A549 control cells or A549
STAT1 KO cells (Fig. 1A). To assess de novo generation of cbVGs,
we started with a parental virus stock (Passage 0, P0) that contained low levels of cbVGs. We confirmed the low cbVG content by
our previously established reverse transcription polymerase chain
reaction (RT-PCR) method and RNAseq/VODKA2 pipeline (Table 1)
(Sun et al. 2015; 2019). We carried out three experimental evolution replicates (three lineages) for each cell line and repeated
this experiment independently three times. For simplicity in visual
representation, one representative repeat is shown throughout.
As expected, RSV replication, as measured by titer, was overall
higher in A549 STAT1 KO cells than in A549 control cells, at least
for the first fourteen passages, for all three lineages (Fig. 1B). RSV
replication dropped to very low levels for several passages in A549
control cells, whereas RSV replication was maintained to high levels throughout the experiment in A549 STAT1 KO cells (Fig. 1B). To
assess how cbVGs evolved in these two cell lines, we performed
RNAseq followed by analysis using VODKA2 for the detection of
cbVGs in P0 and in Passage 20. cbVG junction reads were detected
in all samples, and cbVG content increased significantly more in
virus populations passaged in A549 STAT1 KO cells (S1–S3) than in
A549 control cells (C1–C3) (Table 1 and Fig. 1C). These data demonstrate that an environment that does not allow RSV to maintain
high replication levels, such as A549 control cells, impedes cbVG
accumulation. However, an environment that allows RSV to maintain high replication levels, such as A549 STAT1 KO cells, promotes
cbVG accumulation. This is consistent with the literature as most
studies use permissive cells or cells with innate immune defects
to generate viral stocks with a high cbVG content (Santak et al.
2015; Sun and Lopez 2016; Welch et al. 2020; Tilston-Lunel et al.
2021).

3.2 Short cbVGs accumulate after twenty
passages in A549 STAT1 KO cells but not in A549
control cells
We next determined the break (where the polymerase fell off)
and rejoin (where the polymerase reattached) genome position
of the cbVGs present in each sample (Fig. S1A). As cbVGs unique
sequence and size can be predicted by its break/rejoin positions,
we used these data to determine if different cbVG species were
present in our samples. In previous studies, we set up VODKA to
detect cbVGs generated only on the last 3000 bp of the RSV genome
as we were only interested in the cbVG species with the most reads
(Sun et al. 2019). However, in this study, we assessed the entire
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Nasopharyngeal aspirates from pediatric patients were obtained
from the Children’s Hospital of Philadelphia (CHOP). The CHOP
cohort was previously described in detail (Felt et al. 2021). All
samples used were banked samples obtained as part of standard
testing of patients. Samples were deidentified and sent to our
laboratory for RNA extraction and cbVG detection.
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Table 1. RNAseq/VODKA2 data of parental virus population and Passage 20 virus populations.

Junction reads
(=cbVG reads)

Normalized cbVG
reads per 106 virus
reads

Median break
position (IQR)

Median rejoin
position (IQR)

Median predicted
cbVG size in bp
(IQR)

Sample

Non-junction reads
(=virus reads)

P0

1,823,842

513

281

3,480 (1927–7289)

3,658 (1967–7636)

2,3345 (15489–26534)

C1

3,967,544

3,923

989

2,779 (1577–4412)

2,929 (1625–4506)

24,701 (21575–27258)

C2

2,600,483

2,167

833

2,828 (1581–4417)

2,929 (1695–4738)

24,680 (21050–27155)

C3

3,407,084

2,743

805

2,828 (1581–4417)

2,945 (1698–4740)

24,640 (21468–27155)

S1
S1
S1

358,301
247,193
339,583

603
393
624

1,683
1,590
1,838

1,4596 (2786–15036)
11,751 (1831–14724)
11,341 (2353–14895)

15,058 (2905–15175)
11,769 (1926–15048)
11,415 (2379–15182)

794 (236–24757)
6,931 (675–26693)
7,693 (370–25721)

IQR = interquartile range

cbVG population, and thus, we set up VODKA2 to identify cbVG
junction reads generated through the entire RSV genome.
We observed that more cbVGs in virus populations from A549
STAT1 KO cells had break and rejoin positions in the last 3000 bp
of the RSV genome (dashed box) corresponding to cbVG species
of predicted shorter size as compared to virus populations from
A549 control cells (Fig. 2A). This is consistent with our previous
study where we showed that RSV populations with high cbVG content had break and rejoin hotspots toward the trailer end of the
RSV genome (Sun et al. 2019). However, by running VODKA2 on
the entire genome, we discovered novel cbVG species with break
and rejoin positions outside the 3000 bp range and many with predicted sizes longer than the genome (Figs 2A and S1B). It is also
important to note that most cbVG species detected in P20 were
not present in P0. We found that between 90.5 per cent and 95.9 per
cent of cbVG species in the six P20 cbVG populations were de novo
generated rather than being carried over from P0.
To consider variability and stochasticity in cbVG species
generation and accumulation, we also plotted the median
break (Fig. 2B), rejoin (Fig. 2C), and predicted size (Fig. 2D) for
each lineage (Table 1). The median values of the three lineages
in each condition were similar, and the differences observed in
break, rejoin, and predicted size in different conditions were
statistically different (Fig. 2B–D). Finally, we observed that in
each A549 STAT1 KO cells, lineage (S1–S3) cbVG species of short
sizes started to dominate the cbVG population after twenty

passages (Fig. 2A and E). Taken together, our data show that cbVG
populations are diverse, that cbVGs are generated across the entire
genome, and that short cbVG species are selected for in permissive A549 STAT1 KO cells. This selection was not observed in virus
populations passaged in more resistant A549 control cells. Instead,
long cbVGs remained predominant, and no individual longer cbVG
species outcompeted the others.

3.3 Longer predicted cbVGs are predominant in
nasal washes of hospitalized RSV-infected
pediatric patients
We detected predominantly cbVG species of longer predicted sizes
in virus populations from A549 control cells (Fig. 2A). Longer predicted cbVG species were also present in virus populations from
A549 STAT1 KO cells; however, they were outcompeted by shorter
cbVG species (Fig. 2A and E). In both cell lines, longer predicted
cbVGs species had fewer reads, which indicates that they do not
accumulate as much as the shorter cbVG species (Fig. 2A). To
determine whether long cbVGs are of biological significance, we
sought to assess if longer predicted cbVGs could be detected during natural infections. We have previously shown that detection
of RSV cbVGs in nasal secretions of infected patients is associated with distinct clinical outcomes. To determine what cbVG
species are generated in natural RSV infections, we chose six representative samples from RSV-infected pediatric patients, which
were previously confirmed to contain cbVGs by our pan-cbVG
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Figure 1. Experimental evolution design and detection of infectious viral particles and cbVGs. (A) Schematic of experimental evolution experiment. (B)
TCID50 assay was performed on Hep2 cells for all samples. Dashed lines indicate the minimum and maximum TCID50 /ml values reached in the
experiment. (C) cbVG reads detected by VODKA2 were normalized per 106 virus reads. Data are shown as mean ± SEM. Significant P value for the
two-tailed unpaired t test between A549 control and A549 STAT1 KO (n = 3 lineages) is indicated.

S. A. Felt et al.
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species RT-PCR approach (Felt et al. 2021). We first extracted
RNA from the nasal washes and analyzed them following our
RNAseq/VODKA2 pipeline. We observed that cbVGs generated
within the last 3000 bp of the genome (dashed box) were almost
absent in the samples, and mostly cbVG species of longer predicted size were detected (Fig. 3 and Table 2). These results indicate
that cbVGs species of a longer predicted length are also generated during natural infections and are the most predominant
cbVG species. Overall, although cbVGs of longer predicted size do
not accumulate as much as short cbVGs in vitro (Fig. 2A and E),
these newly discovered species of cbVGs are predominant in vivo

(Fig. 3) and associate with distinct clinical outcomes as reported
in our previous study (Felt et al. 2021), emphasizing the importance of taken them in consideration when studying RSV cbVG
populations.

3.4 Virus replication levels drive cbVG species
selection
We next investigated what drives the difference in cbVG populations at Passage 20 between A549 control cells and A549 STAT1 KO
cells. As cbVGs are dependent on the virus replication machinery
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Figure 2. cbVG species in A549 control and A549 STAT1 KO cells at Passage 20. (A) Each dot represents a cbVG species and its break/rejoin position. The
size of the dots represents the number of normalized reads per 106 virus reads. The percentage of cbVG reads within the last 3000 bp of the RSV
genome (dashed box) is indicated above each plot. (B-D) Mean break position, rejoin position, and predicted cbVG size are shown in these graphs. Each
dot represents the median of a lineage. Data are shown as mean ± SEM. Significant P values for the two-tailed unpaired t test between A549 control
and A549 STAT1 KO (n = 3 lineages) are indicated. (E) Stacked bar graph shows cbVG species with at least 100 reads present in each sample. The legend
includes information on break position, rejoin position, and predicted cbVG size. cbVG species with less than 100 reads were grouped together as
‘Others’.
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Table 2. RNAseq/VODKA2 data of clinical samples.

Sample
cl2
cl59
cl79
cl87
cl99
cl103

Median break
position (IQR)

Median rejoin
position (IQR)

Median predicted cbVG
size in bp (IQR)

3,286
(2222–5134)
9,3661
(2249–4935)
2,981
(2000–4226)
4,361
(3014–4794)
4,582
(3556–4794)
3,892
(3027–4794)

3,352
(2300–5170)
3,705
(2333–4982)
3,030
(2032–4267)
4,377
(3031–4820)
4,608
(3589–4820
3,923
(3060–4821)

23,835
(20160–25942)
23,017
(20526–25828)
24,445
(21969–26428)
21,726
(20854–24422)
21,275
(20854–23317)
22,655
(20854–24370)

IQR = interquartile range

to be generated and replicated, we hypothesized that STAT1 exerts
selective pressure on cbVGs by limiting virus replication and
thereby driving their evolution within a virus population. To determine how cbVG populations evolved over time in control and
STAT1 KO cells, we analyzed Passages 0, 4, 8, 12, 16, and 20 using
our RNAseq/VODKA2 pipeline for all three lineages.
To assess this hypothesis, we first compared virus replication kinetics to the cbVG population diversity (Shannon’s Entropy)
kinetics in control and STAT1 KO cells using virus read as a proxy
for replication (Fig. 4A and B). We noticed that cbVG population
diversity kinetics followed the same pattern than virus replication
kinetics (Fig. 4A and B). These data also show that a permissive host environment, such as STAT1 KO cells, that allows RSV
replication to be sustained at high levels will promote a more
diverse cbVG population early on (Passages 4, 8, and 12). As Shannon’s entropy takes in consideration both richness (number of
species present in a population) and evenness (relative abundance of each species in a population), we also analyzed cbVG

species richness kinetics and the proportion of cbVGs within the
last 3000 bp of the RSV genome over time. We observed that cbVG
species richness kinetics also followed virus replication kinetics
and that RSV generated more cbVG species early on (Passages 4,
8, and 12) in STAT1 KO cells (Fig. 4C). Interestingly, at Passages
16 and 20, Shannon’s entropy and cbVG species richness dropped
significantly in STAT1 KO cells and were even lower than control cells. To understand this observation, we next looked at the
proportion of cbVGs within the last 3000 bp of the RSV genome
(= predicted short cbVGs) (Fig. 4D). We measured this proportion in two ways: (1) percentage of predicted short cbVG species
found in the sample (empty circles) and (2) percentage of predicted short cbVG reads found in the sample (full circles). In
STAT1 KO cells, at Passages 16 and 20, RSV generated more of the
shorter cbVGs species (empty circles) that also accumulated significantly (full circles) (Fig. 4D). These data suggest that predicted
shorter cbVGs outcompeted the predicted longer cbVG species,
which led to the drop in cbVG population diversity and richness
in STAT1 KO cells at Passages 16 and 20. Importantly, only when
the predicted short cbVGs predominated the cbVG population
(Passage 20), we observed a significant increase in cbVG content
in STAT1 KO cells (Fig. 4E). In rare circumstances, such as Passage
8 from control lineage 3, where virus reads dropped significantly,
but a few cbVGs reads could still be detected (13 cbVG reads/6073
virus reads), cbVG content was also high in relationship to virus
reads (Fig. 4E). Whether this is technical (e.g., threshold of detection) or biological (e.g., predicted long cbVGs are very stable in the
absence of helper virus) is unknown. We also tracked the most
predominant cbVG species in the three STAT1 KO cell lineages
and observed that they were not present at P0 and were detected
first at Passage 16 (Fig. 4F–H). This result indicates that predicted
shorter cbVGs were de novo generated before being selected and
outcompeting other cbVGs.
Overall, these data show that longer predicted cbVG species
are predominant in both cell lines until sustained high virus
replication levels lead to diversification and generation of shorter
cbVGs. In STAT1 KO cells, where high virus replication levels
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Figure 3. cbVGs in nasal washes of RSV-infected hospitalized pediatric patients. Each dot represents a cbVG species and its break/rejoin position. The
size of the dots represents the number of normalized reads per 106 virus reads. The percentage of cbVG reads within the last 3000 bp of the RSV
genome (dashed box) is indicated above each plot.
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were maintained throughout the experiment, we observed that
shorter cbVGs were selected and accumulated, which allowed for
an increase in the overall cbVG content within the virus population. However, in control cells, this selection was not observed,
likely because high virus replication levels were not maintained
throughout the experiment and peak virus replication levels were
not reached before Passage 20.
To more directly address if virus replication levels are the major
driver of cbVG selection, we serially passaged RSV at a fixed MOI
of either 0.1 or 10 in both A549 control and STAT1 KO cells for
ten passages. As opposed to the fixed-volume experiment, these
conditions would normalize virus replication levels between control and STAT1 KO cells throughout the experiment. A MOI of 0.1
was chosen to maintain virus replication levels low, and a MOI of
10 was chosen to maintain virus replication levels high. As with
the fixed-volume experiment (Fig. 1A), we carried out three experimental evolution replicates for each cell line. We hypothesized
that if sustained high replication levels is the major driver of short
cbVG selection, we should observe selection of short cbVGs only
at a fixed MOI of 10 in both cell lines due to normalization of virus
replication levels.

As expected, RSV replication levels, as measured by titer,
were similar between control and STAT1 KO cells throughout the
experiment for both MOIs (Fig. 5A and B). We analyzed P0 and P10
viral stocks using the RNAseq/VODKA2 pipeline and found that
RSV populations contained more cbVGs when passaged at an MOI
of 10 than 0.1 in both cell lines (Fig. 5C). At a MOI of 10, we noticed
an accumulation of cbVGs with break and rejoins occurring in
the last 3000 bp of the RSV genome (dashed box) corresponding
to cbVGs of short length regardless of the cell line (Fig. 5D). This
accumulation did not occur at an MOI of 0.1 where mainly longer
cbVGs were present (Fig. 5D). To assess if the differences observed
were consistent between lineages, we plotted the median break,
rejoin, and predicted size values for each lineage in each condition (Fig. 5E–G). All three analyses showed more drastic differences
between MOIs of 0.1 and 10 than among control and STAT1 KO
cells, which we expected due to normalization of virus replication
levels between cell lines (Fig. 5E–G). At a MOI of 10, we noticed
selection of shorter cbVG species that dominated the cbVG population (Fig. 5H), similar to what we observed in STAT1 KO in the
fixed-volume experiment (Fig. 2E). Notably, at Passage 10, some
of the most predominant cbVGs species were of longer predicted
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Figure 4. Sustained high replication levels in A549 STAT1 KO drive the selection of short cbVG species. (A) Line graph shows virus reads normalized per
forty million total raw reads for different passages in A549 control or STAT1 KO cells. (B) Line graph shows Shannon’s entropy for different passages in
A549 control or STAT1 KO cells. Shannon’s Entropy for each population was calculated using the formula -Σpi ln(pi ), where pi is the relative abundance
(proportion) of species i. (C) Line graph shows cbVG species richness for different passages in A549 control or STAT1 KO cells. (D) Line graph shows %
cbVG species (empty circles) or reads (full circles) within the last 3000 bp of RSV genome for different passages in A549 control (blue) or STAT1 KO
(pink) cells. (E) Bar graphs show cbVG reads normalized to one million virus reads. (A–E) Data are shown as mean ± SEM. P values for two-way analysis
of variance (ANOVA) with the Bonferroni post hoc test comparing all passages (n = 3 lineages) to P0 (n = 2). (F-H) Continuous stacked bar graph shows
cbVG species with at least 100 reads present in each sample of lineage 1, 2, and 3 of A549 STAT1 KO. The legend includes information on break
position, rejoin position and predicted cbVG size. cbVG species with less than 100 reads were grouped together as ‘Others’.
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Figure 5. Selection of short cbVG species only occurs at high MOI conditions. (A and B) TCID50 assay was performed on Hep2 cells for all samples from
fixed-MOI 0.1 and 10 experiment. Dashed lines indicate the minimum and maximum TCID50 /ml values reached in each experiment. (C) cbVG reads
detected by VODKA2 were normalized per 106 virus reads. Each dot represents the median of a lineage. Data are shown as mean ± SEM. (D) Each dot
represents a cbVG species and its break/rejoin position. The size of the dots represents the number of normalized reads per 106 virus reads. The
percentage of cbVG reads within the last 3000 bp of the RSV genome (dashed box) is indicated above each plot. (E-G) Mean break position, rejoin
position and predicted cbVG size are shown in these graphs. Each dot represents the median of a lineage. Data are shown as mean ± SEM. P values for
one-way analysis of variance with the Bonferroni post hoc test for all groups are indicated. (H) Stacked bar graph shows cbVG species with at least 100
reads present in each sample. The legend includes information on break position, rejoin position, and predicted cbVG size. cbVG species with less than
100 reads were grouped together as ‘Others’.
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length than the most predominant species at Passage 20 in the
fixed-volume experiment, suggesting that the average length of
accumulated cbVG species gets shorter over time (Figs 2E and 5H).
Finally, we did observe that shorter cbVG species tended to accumulate more in STAT1 KO than control cells during the MOI of 10
passages, suggesting that other factors might play a minor role
alongside virus replication levels (Fig. 5D–H).
We also compared the fixed-volume versus fixed-MOI experiments more directly (Fig. S2). Virus titers in the fixed-volume
control and MOI of 0.1 experiments never went above 2 × 107
TCID50 /mL (see the dashed line); however, in the fixed-volume
STAT1 KO and MOI 10 experiments, virus titers were sustained
above this threshold over longer time periods (Fig. S2A). We also
compared the distribution of break, rejoin, and size between the
two experiments and observed a shift in distribution only in the
fixed-volume STAT1 KO and MOI 10 experiments (Fig. S2B–S2C).
These data again emphasize how virus replication levels need to
be sustained above a certain threshold to generate and accumulate predicted shorter cbVGs.
Taken together, these data confirm that sustained high MOI
(high replication) conditions are a main driver of the generation
and selection of short cbVGs that accumulate within virus populations. We also show that more resistant cell lines, such as A549
control, which were not susceptible to cbVG accumulation in the
fixed-volume experiment, can accumulate cbVGs if saturated by
high MOI conditions. Meanwhile, the more permissive cell line
A549 STAT1 KO, which was susceptible to cbVG accumulation in
the fixed-volume experiment, does not accumulate cbVGs if MOI
conditions are maintained to very low levels.

4. Discussion
Although nonstandard viral genomes play a crucial role in shaping virus infection outcomes (Sun et al. 2015; Vasilijevic et al. 2017;
Felt et al. 2021), the principles that drive the selection and evolution of non standard viral genomes within a virus population
are poorly understood. In vitro, nonstandard viral genomes usually

accumulate within virus populations when RNA viruses are serially passaged at a high MOI (Von Magnus 1951; 1954; Kingsbury,
Portner, and Darlington 1970; Stampfer, Baltimore, and Huang
1971; Huang 1973; Thompson and Yin 2010; Sun and Lopez 2016;
Welch et al. 2020). These studies suggest that accumulation of
nonstandard viral genomes is favored by increasing the number
of cells infected, the virus replication within cells, and/or the
number of co-infected cells with standard and nonstandard viral
genomes. However, how nonstandard viral genome populations
change when an increase in the cbVG content of a virus population
occurs remains unknown.
Nonstandard viral genomes of the copy-back type are historically described as significantly shorter than standard viral
genomes (Huang and Wagner 1966; Kingsbury, Portner, and
Darlington 1970; Huang 1973; Lazzarini, Keene, and Schubert
1981; Vignuzzi and Lopez 2019), and it is unclear if the bias for
a shorter size is due to preferential generation of short cbVGs,
faster replication rate and accumulation of short cbVGs, and/or
due to limitations in detection methods. It is also not clear how
cbVG species are selected for under different environmental conditions and how this selection impacts the evolution of the overall
cbVG population. In this study, we addressed how cbVG selection
and cbVG population evolution are affected by a permissive host
environment that allows sustained high replication levels (A549
STAT1 KO cells) or a resistant host environment that limits replication levels (A549 control cells). Overall, we found that cbVGs
of a longer predicted size predominate first and that sustained
high RSV replication levels lead to cbVG population diversification.
This diversification primes the generation and selection of shorter
cbVGs that later accumulate and allow for an increase in the cbVG
content within a virus population (Fig. 6).
It is important to note that although permissive STAT1 KO cells
accumulated significantly more cbVGs than resistant control cells,
cbVGs were found in both cell lines (Fig. 1B and Table 1). These
data suggest that accumulation but not generation of cbVGs is
dependent on sustained high virus replication. This is consistent
with our recent study where we showed that cbVGs were found
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Figure 6. Schematic summary of cbVG population evolution in resistant and permissive hosts. Summary of the cbVG population changes observed in
our study over time in different host environments.
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are predicted to be longer than the genome (Fig. S1B). It is possible that previous studies did not detect these longer cbVGs due to
lack of sensitivity in the methods used. The fact that we detected
these longer cbVGs in patients raises the question on how they are
functionally different from the shorter cbVGs, which have been
studied so far in vitro. Do they interact with different pattern recognition receptors and/or induce different signaling pathways? Why
do we mainly find longer cbVGs in patients and less shorter ones?
Is there a fitness advantage of these longer cbVGs in vivo? We must
also consider that we are limited to nasal samples from patients
and that cbVG populations could differ between microenvironments (e.g., nose vs. lung) as has been shown for Zika nonstandard
viral genomes (Johnson et al. 2020). However, we have observed
that Sendai virus (SeV) populations in the lung of mice also consist
of mainly longer cbVGs, indicating that this might be a common
feature of in vivo cbVG populations (unpublished data). Further
characterization of longer cbVGs is still needed as we can only
extract predicted sizes based on VODKA2. Due to their size and
complex structure, amplifying or sequencing the entire sequence
of long cbVGs by RT-PCR or MinION remains a challenge. So far,
we were able to confirm that the junction regions at least are not
artifactual as we did not detect copy-backs when running VODKA2
using a RSV database (negative control for false positivity rate
of VODKA2) or Glyceraldehyde 3-phosphate dehydrogenase/actin
databases (negative controls for library prep generating copyback sequences) on SeV samples (Fig. S5A). Interestingly, cbVG
species of longer predicted size never accumulated to significant
amounts, strongly suggesting that they are indeed of longer size
and hence not as competitive against the standard viral genome
or shorter cbVG species (Fig. S4). However, it is important to note
that many predicted long cbVG species can be detected in several
passages and follow virus kinetics, which suggests that they could
potentially be replicated and packaged (Fig. S5B).
Nonstandard viral genomes can interfere with standard viral
genome replication when they accumulate to significant levels
causing a significant drop in infectious virus particles (Palma and
Huang 1974; Kirkwood and Bangham 1994; Manzoni and Lopez
2018; Genoyer and Lopez 2019). Although cbVGs did accumulate to significant levels in STAT1 KO cells, we did not observe
such a significant decrease in infectious virus particles in the
fixed-volume experiment (Fig. 1B). This is likely due to cbVGs
being less interfering in the absence of antiviral responses (e.g.,
mediated by STAT1), such as has been shown for RSV and
parainfluenza virus 5 (Sun et al. 2015; Wignall-Fleming et al.
2020).
Currently, they are few studies showing what roles host proteins could play in nonstandard viral genome generation, accumulation, and selection (Holland, Villarreal, and Breindl 1976;
Kang and Allen 1978). We have previously shown that children are
more likely to accumulate RSV cbVGs than adults and that female
patients are more likely to accumulate RSV cbVGs than males (Felt
et al. 2021). Furthermore, in an adult cohort, although all patients
were experimentally infected with the same virus (RSV Memphis
37), not all patients accumulated cbVGs (Felt et al. 2021). All these
studies strongly suggest that the host might play an important role
in shaping cbVG populations. In this study, we have shown that
STAT1 by limiting virus replication can exert selective pressure on
cbVG populations and shape their evolution. It will be important to
assess in future studies what other host proteins can shape cbVG
content within virus populations.

Data availability
Raw sequence data are deposited on SRA (PRJNA837014).
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in nasal washes of experimentally RSV-infected adult patients
before high virus replication levels were reached (Felt et al. 2021).
Taken together, our study also shows that the generation of cbVGs
is inherent to RSV replication and that most RSV populations will
contain cbVGs. This is likely true for many other RNA viruses and,
as cbVGs have been shown to play a crucial role in virus infections, our data underlines the need to consider cbVGs in the study
of RNA virus populations.
Next-generation sequencing and pipelines to analyze virus
populations have improved significantly in recent years (Routh
and Johnson 2014; Timm, Akpinar, and Yin 2014; Jaworski and
Routh 2017; Beauclair et al. 2018; Bosma et al. 2019; Boussier et al.
2020; Olmo-Uceda et al. 2022). In this study, we used an updated
version of our previously published RNAseq/VODKA pipeline,
called VODKA2, to study cbVG populations (Sun et al. 2019).
Previous methods such as RT-PCR more efficiently detect short
cbVGs that are of high abundance; however, our RNAseq/VODKA2
pipeline can overcome these challenges and detect unbiasedly
cbVG species of various predicted sizes and abundance (Fig. 2A).
Therefore, VODKA2 revealed that the diversity of cbVGs generated by RSV is much larger than previously thought. The use
of stranded total RNA library preparation kits can further allow
VODKA2 to determine if cbVGs are only generated (only genomic)
or are also being replicated by the viral polymerase (mixture of
genomic and antigenomic). From a stranded library preparation
on P0, P20 C1–C3, and P20 S1–S3, we were able to determine that
39.77 per cent of cbVGs were genomic and 60.23 per cent of cbVGs
were antigenomic, indicating that cbVGs were not only generated
but also replicated (Fig. S3). Furthermore, short cbVGs (especially shorter than 6000 bp) correlated with more reads. indicating
that short cbVGs are more likely to replicate more efficiently as
has been shown previously for some nonstandard viral genomes
(Fig. S4) (Laske et al. 2016; Mendes and Russell 2021; Pelz et al.
2021). Overall, these data suggest that sustained high replication
drives the generation of shorter cbVGs; however, it is likely that
the highly efficient replication of short cbVGs ultimately leads to
their accumulation and an overall increase in the cbVG content
within a virus population.
Our RNAseq/VODKA2 pipeline also allowed us to compare
cbVG species between virus populations from the cell line that
limited virus replication (A549 control cells) and the cell line that
allowed high virus replication (A549 STAT1 KO cells). The virus
population observed in STAT1 KO cells mainly consisted of shorter
cbVGs, whereas the virus population from control cells consisted
mainly of much longer cbVGs. A fixed-MOI passaging experiment
confirmed that it was sustained high virus replication levels that
drive the selection of shorter versus longer cbVGs. In the fixedvolume passaging experiment, we observed that sustained high
virus replication over several passages drives cbVG diversification
and generation of short cbVGs that will significantly accumulate (Fig. 4). This demonstrates that high virus replication does
not directly lead to cbVG accumulation and instead requires an
intermediate step that consists of cbVG diversification and generation of short cbVGs, which then accumulate and take over the
cbVG population (Fig. 6). The exact molecular mechanism that
drives the generation of shorter cbVGs is not clear. Are shorter
cbVGs generated from longer ones? Do high virus replication levels affect the processivity of the polymerase directly or maybe
indirectly through host factors? Future studies will address these
questions.
In this study, we also discovered the first evidence of cbVGs
of long predicted sizes. These cbVGs are predominant at first in
vitro and are the most predominant in vivo. Some of these cbVGs
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